Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR-TEER Ⅱ: Antithrombotic Strategies Following TEER
NCT07007143Phase 4Recruiting
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2025
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel in mitral regurgitation (MR), sponsored by Chinese Academy of Medical Sciences. Started Jul 2025; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
mitral regurgitation (MR)
Beyond the preview
Go deeper on NCT07007143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007143.